Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001493152-22-013802

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 16, 2022 78.7M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$30
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$6.93K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $5.92K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $5.95K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$2.7M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$2.64M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$2.44M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$2.38M
Total Liabilities Q1 2022 · Mar 31, 2022 $2.7M
Total Liabilities Q1 2022 · Dec 31, 2021 $2.65M
Current Assets Q1 2022 · Mar 31, 2022 $5.92K
Current Assets Q1 2022 · Dec 31, 2021 $5.95K
Total Assets Q1 2022 · Mar 31, 2022 $5.92K
Total Assets Q1 2022 · Dec 31, 2021 $5.95K
Eps Basic Q1 2022 · Mar 31, 2022 $0.00
Eps Basic Q1 2022 · Mar 31, 2021 $0.00
Sga Expense Q1 2022 · Mar 31, 2022 $3.61K
Sga Expense Q1 2022 · Mar 31, 2021 $3.55K
Net Income Q1 2022 · Mar 31, 2022 −$57.49K
Net Income Q1 2022 · Mar 31, 2021 −$59K
Operating Income Q1 2022 · Mar 31, 2022 −$3.61K
Operating Income Q1 2022 · Mar 31, 2021 −$5.05K